How many clinical trials are tracked of teprotumumab?

3 trials are tracked, 2 with published results.

Mode

All Oncology Infectious Disease Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Anesthesiology & Pain Medicine Genetics & Precision Medicine Pulmonology & Critical Care Physical Medicine & Rehab Nephrology Urology Emergency Medicine Dermatology Hematology Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

teprotumumab

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of teprotumumab

3 trials tracked of teprotumumab: 2 in phase 3 or 4 and 2 with published results. The most-cited published study has 752 citations.

3Trials tracked

2Phase 3 & 4

0Recruiting

2With published results

Phase distribution

Phase 3 2 Phase 2 1

Phase 3 Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis With Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study Completed · 752 cited
Phase 3 Treatment of Graves' Orbitopathy to Reduce Proptosis With Teprotumumab Infusions in an Open-Label Clinical Extension Study Completed · 29 cited
Phase 2 Teprotumumab (RV 001) Treatment in Patients With Active Thyroid Eye Disease Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.